. . . . . . . . . "Vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss" . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCC0CnI6yMUipkXh7RB8b/9rRnO8+qDR+pJVf//jGV0r2nd7JcvWFkhPN/eLja/pUw/+nvTE24rhKqK/jWxppJLoka+bk57wrYw43DrSbzQWoJc3ImWe3d08jSYt3mh3uOLWKciogBaonJUBohJsqhTmOULevIPONTZOMzeOJTWwQIDAQAB" . "SMoY3+Pw5txXR4ZS30apawCoROuFB2DscfnJCZWppVJj1jABDMESHkL56KkWUy5p5t4NfcWw1WKgRbv6KiQzlvtMt5962ewi0iVtCOqiHT/2yctQJiE5IFFkEfj8WifovUpOCFjSHKYBD+MucC7WkAmbuiGW60pmp6Dp/s6QRo8=" . . "2021-04-04T21:36:27.877+02:00"^^ . . . . .